Arrowhead Pharmaceuticals Inc. buy Chardan Capital
Start price
26.06.24
/
50%
€25.44
Target price
26.06.25
€56.18
Performance (%)
-15.80%
Price
09.08.24
€21.42
Summary
This prediction is currently active. The price of Arrowhead Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.80%. This prediction currently runs until 26.06.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | -10.787% | -10.787% |
| iShares Core DAX® | 0.393% | -2.618% |
| iShares Nasdaq 100 | 0.394% | -10.309% |
| iShares Nikkei 225® | 1.038% | -8.365% |
| iShares S&P 500 | -0.046% | -4.991% |
Comments by Chardan_Capital for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $60.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Chardan_Capital for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.45
18.07.24
18.07.24
€54.83
18.07.25
18.07.25
-15.84%
09.08.24
09.08.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.45
18.07.24
18.07.24
€54.83
18.07.25
18.07.25
-15.84%
09.08.24
09.08.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.62
03.06.24
03.06.24
€55.13
03.06.25
03.06.25
-5.31%
09.08.24
09.08.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€20.70
10.05.24
10.05.24
€55.70
10.05.25
10.05.25
3.48%
09.08.24
09.08.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.07
08.08.23
08.08.23
€54.73
08.08.24
08.08.24
-10.25%
09.08.24
09.08.24